n n n n n n n n n
h Edition, By Mottram
n n n
Chapter 1 - 13 Updated
n n n n n
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
n n n n n n n n
MULTIPLEnCHOICE
1. Whonfirstnpopularizednspirometrynfornthenevaluationnofnpulmonarynfunction?
a. AugustnandnMarienKrogh
b. AlvannBarach
c. JohnnSeveringhaus
d. JohnnHutchinson
ANS:nD
HutchinsonnpopularizednthenconceptnofnusingnVCntonassessnlungnfunction,nandnthennamesnhenga
ventonseveralnothernlungncompartmentsnarenstillnusedntoday.
DIF: 1 REF: p.n2 OBJ: Nonen MSC:nNBRC:nNone
2. Whichnofnthenfollowingnarenindicationsnfornperformingnspirometry?
1. Assessnthenrisknofnlungnresection.
2. Determinenthenresponsentonbronchodilatorntherapy.
3. Assessnthenseveritynofnrestrictivenlungndisease.
4. QuantifynthenextentnofnCOPD.
a. 1n andn 4
b. 2n andn 3
c. 1n,n2,nandn 4
d. 2n,n3,nandn 4
ANS:nC
Spirometryncannotnassessnseveritynofnrestriction;nfornthatnyounneedntonmeasurenlungnvolumesn(
nseenBoxn1-2,nChaptern 1).
DIF: 1 REF: p.n7 OBJ: EL-2 MSC:nNBRC:nNone
,3. Thenmainnindicationnfornthenmeasurementnofnlungnvolumesnisntondonwhichnofnthenfollowing?
a. Diagnosenornassessnthenseveritynofnrestriction.
b. Evaluatenthenseveritynofnpulmonarynhypertension.
c. Determinenthenlevelnofncardiopulmonarynfitness.
d. Assessnthenrisknofnabdominalnsurgicalnprocedures.
ANS:nA
Thenmostncommonnreasonnfornmeasuringnlungnvolumesnisntonidentifynrestrictivenlungndisease
.nDIF: 1 REF: p.n35 OBJ: EL-2 MSC:nNBRC:nNone
4. DLCOnmeasurementsnmaynbenindicatedntonevaluatenpulmonaryninvolvementninnwhichnofnth
enfollowingnsystemicndiseases?
a. Asthma
b. Sarcoidosis
c. Exertionalnhypoxemia
, Stuvia.comn-
nThenMarketplacentonBuynandnSellnyournStudynMaterial
d. Guillain-Barrénsyndrome
ANS:nB
Sarcoidosisnisnthenonlynsystemicndiseasenlistednthatnaffectsngasnexchange.n
DIF:n1nREF:np.n9n|np.n19n|np.n21n|np.n35nOBJ:nEL-2nMSC:nNBRC:nNone
5. BloodngasnanalysisnisnusednwithnpatientsnwithnCOPDntondonwhichnofnthen
following?
a. Monitornairwaynresponsiveness.
b. Determinenlevelnofncardiopulmonarynfitness.
c. Detectnpulmonarynhypertension.
d. AssessnneednfornsupplementarynO2.
ANS:nD
Bloodngasnanalysisnisnmostncommonlynusedntondeterminenthenneednfornsupplementalnoxygenn
andntonmanagenpatientsnwhonrequirenventilatorynsupport.
DIF: 2 REF: p.n15 OBJ: EL-
1nMSC:nNBRC:nCPFTn2A-2
6. Whichnofnthenfollowingncausenemphysema?
1. 1-nAntitrypsinndeficiency
2. Exposurentonenvironmentalnpollutants
3. Radiationntherapy
4. Cigarettensmoking
a. 1n andn 2
b. 3n andn 4
c. 1n,n2,nandn 4
d. 2n,n3,nandn 4
ANS:nC
Emphysemanisncausednprimarilynbyncigarettensmoking.nSomenemphysemanisncausednbynthenabs
encenofnanprotectivenenzyme.nChronicnexposurentonenvironmentalnpollutantsncannalsoncontrib
utentonthendevelopmentnofnemphysema.
DIF: 1 REF: p.n11 OBJ: EL-3n|nAL-2 MSC:nNBRC:nNone
7. Annadultnpatientncomplainsnofnchestntightnessnandncoughnwhenevernhenjogsninncoldnweathe
r.nThesensymptomsnarenconsistentnwithnwhichnofnthenfollowing?
a. Cysticnfibrosis
b. Asthma
c. Pulmonarynhypertension
d. Idiopathicnpulmonarynfibrosis
|